Global University Venturing

Kaiser Permanente contributed to a round that pushed the total raised by the Stanford-aligned cellular cancer therapy developer to $300m.

MIT Media Lab's E14 fund has contributed to a round that will fund research and development for the logistics management platform developer.

Rutgers University-New Brunswick has spun out Infinity Biologix with backing from Viking Global Investors to manage the distribution of a saliva-based coronavirus test.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

TU Delft and Imperial-founded genetic data analytics software provider BlueBee has been picked up after raising at least $13.5m of funding.

Vanderbilt University was among the participants in a $75.9m round for Monzo that cut the mobile bank's valuation from more than $2.5bn to under $1.6bn.

Grand Decade and existing investor Boehringer Ingelheim Venture Fund helped supply $38.2m for the mRNA immunotherapy developer and Vrije Universiteit Brussel spinout.

Uniseed has entered a co-investment pact with BioCurate, a drug discovery fund for early-stage University of Melbourne and Monash University research.

Founded by University of Washington faculty, Proprio has raised series A funding to commercialise its multi-camera surgical imaging system.

Chalmers Ventures portfolio company Biofrigas has set out plans for a $1.7m IPO but has already issued around $1.2m to existing connections.

The carmaker has followed up a $100m investment two years ago with a pledge to provide up to $200m for the Stanford-originated solid-state battery developer.